Skip to content

3ohmyristoleylcarnamnscnc

Published: August 9, 2026Updated: August 16, 2026

This test measures the level of C14:1-OH acylcarnitine in amniotic fluid to evaluate fetal fatty acid metabolism.

Quick summary

{"Measures a specific fatty acid metabolite in amniotic fluid","Used to screen for fetal fatty acid oxidation disorders","Collected during pregnancy through amniocentesis","Helps detect metabolic conditions before birth","Results assist doctors in planning appropriate care"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
50274-0
Short code
3OH-myristoleylcarn Amn-sCnc
Synonyms
3OH-myristoleylcarn Amn-sCnc
Category
chemistry
Sample
fluid
Container
Sterile tube
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
2-5 mL
Stability
Room temperature: 2h, Refrigerated: 24h
Hemolysis max
300
TAT
4–24 hours
Order
routine

What is this test?

The 3-Hydroxymyristoleylcarnitine (C14:1-OH) test measures the amount of a specific fatty acid metabolite called C14:1-OH acylcarnitine in the amniotic fluid that surrounds the unborn baby. Acylcarnitines are substances produced when the body breaks down fatty acids for energy. This test is part of newborn metabolic screening and can also be performed during pregnancy using amniotic fluid to detect potential metabolic disorders in the fetus.

How is the test performed?

During amniocentesis, a small amount of amniotic fluid is collected from the uterus using a thin needle under ultrasound guidance. The fluid sample is then sent to a laboratory where it is analyzed using specialized equipment to measure the levels of various acylcarnitines, including C14:1-OH. The procedure is typically performed between 15-20 weeks of pregnancy.

Why is this test important?

This test helps healthcare providers evaluate how well the fetus is metabolizing fatty acids. Abnormal levels of C14:1-OH may indicate a fatty acid oxidation disorder, which is a group of genetic conditions where the body cannot properly break down fatty acids for energy. Early detection allows for prompt treatment after birth and can prevent serious complications.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Frequently asked questions

Is amniocentesis safe?
Amniocentesis carries a small risk of miscarriage (approximately 1 in 300-500). The procedure is performed under ultrasound guidance to minimize risks. Discuss the benefits and risks with your healthcare provider.
What do abnormal results mean?
Abnormal C14:1-OH levels may indicate a fatty acid oxidation disorder in the fetus. Your doctor may recommend additional testing, genetic counseling, and consultation with a metabolic specialist to confirm the diagnosis and plan appropriate management.
Can this test predict all metabolic disorders?
No, this test specifically measures C14:1-OH and related acylcarnitines. It is most useful for detecting disorders affecting medium-chain fatty acid metabolism. Other metabolic conditions may require different tests.
When will I get my results?
Results typically take 1-2 weeks from the time the sample reaches the laboratory. Your healthcare provider will discuss the results with you and explain what they mean for your pregnancy.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy